Monopar Therapeutics MNPR
NASDAQ MNPR
$73.75 +2.33 (+3.26%)
At close: Nov 9, 2026 · 4:00 PM EST

Monopar Therapeutics (MNPR) Long-Term Investments (2022 - 2026)

Updated

Analysis

Monopar Therapeutics (MNPR) Long-Term Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 387.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - 63.00 Mn
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 1.45 Bn
10 Monopar Therapeutics 630.69 Mn 335.88 Mn - 81.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 81.54 Mn
Dec 31, 2025 78.57 Mn
Sep 30, 2025 16.00 Mn
Jun 30, 2025 13.75 Mn
Mar 31, 2025 14.84 Mn
Dec 31, 2024 14.40 Mn
Jun 30, 2024 998,840.00
Mar 31, 2024 985,730.00
Sep 30, 2023 2.98 Mn
Jun 30, 2023 2.98 Mn
Mar 31, 2023 5.95 Mn
Dec 31, 2022 4.93 Mn
API Access

Monopar Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=MNPR&period=max&api_key=YOUR_API_KEY